Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LXB.STthis companyLuxbright AB (publ)	SEK 6.50	-2.9×	2.09×	4.94×	-3.32×	-5295.1%	-187.2%	-187.2%	-170.5%	-72.4%	-67.9%	-35.3%	0.17×	0.04×	-54.72×	1.38×	0.0%	2	-1.35	2	C+
ARCOMA.STArcoma AB	SEK 8.50	20.97×	1.41×	0.8×	4.36×	-14.6%	5.2%	6.6%	3.8%	6.7%	9.3%	12.5%	0×	-2.2×	73.58×	3.49×	0.0%	6	6.68	3	B+
HEART.STScandinavian Real Heart AB (Publ)	SEK 16.40	-1.96×	1.11×	0×	-3.8×	-85.9%	0.0%	0.0%	0.0%	-56.8%	-22.9%	-23.8%	0.07×	0.8×	-41.14×	2.5×	0.0%	3	8.38	2	C
ICO.STIconovo AB (publ)	SEK 1.10	-1×	0.37×	39.24×	-1.23×	-96.0%	-3959.5%	-3959.5%	-3924.3%	-36.8%	-36.0%	-106.0%	0.04×	0.05×	-97.45×	1.01×	0.0%	4	4.35	2	C+
IDLDX.STIDL Diagnostics AB (publ)	SEK 0.32	-6.7×	0.55×	1.53×	-7.18×	-1307.2%	52.2%	-20.2%	-22.9%	-8.2%	-6.6%	-11.3%	0.09×	2.89×	-24.09×	3.21×	0.0%	3	0.24	4	A
IMMNOV.STImmunovia AB	SEK 0.03	-0.54×	1.21×	114.1×	-0.02×	293.5%	-11606.4%	-11606.4%	-21301.5%	-225.4%	-108.4%	-100.3%	0.01×	0.99×	-1.2×	5.12×	0.0%	1	-42.87	2	C+
Peer median	—	-1×	1.11×	1.53×	-1.23×	-85.9%	0.0%	-20.2%	-22.9%	-36.8%	-22.9%	-23.8%	0.04×	0.8×	-24.09×	3.21×	0.0%	3	4.35	2	—